Published in Hoppe Seylers Z Physiol Chem on May 01, 1976
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Behavioral adjustments of African herbivores to predation risk by lions: spatiotemporal variations influence habitat use. Ecology (2009) 2.60
Comparison of transcutaneous and endtidal CO2-monitoring for rigid bronchoscopy during high-frequency jet ventilation. Acta Anaesthesiol Scand (2003) 2.02
Unusual solution properties of proline and its interaction with proteins. Biochim Biophys Acta (1978) 1.94
Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem (1989) 1.93
[Perforation of the superior vena cava due to unrecognized stenosis. Case report of a lethal complication of central venous catheterization]. Anaesthesist (2001) 1.83
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung (1983) 1.74
Role of fiberoptic bronchoscopy in conjunction with the use of double-lumen tubes for thoracic anesthesia: a prospective study. Anesthesiology (1998) 1.73
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J (1986) 1.71
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J (1994) 1.68
The effect of nisin on murein synthesis. Arch Microbiol (1980) 1.53
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52
A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett (1992) 1.51
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J (1993) 1.49
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
Screening for bacteriuria with a tet paper for glucose. JAMA (1968) 1.45
Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. Hoppe Seylers Z Physiol Chem (1980) 1.45
Structural properties of matrix metalloproteinases. Cell Mol Life Sci (1999) 1.43
Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature (1998) 1.43
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem (1990) 1.43
Effect of mild hypothermia on cerebral oxygen uptake during gradual cerebral perfusion pressure decrease in piglets. Crit Care Med (2000) 1.40
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. EMBO J (1989) 1.38
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest (1997) 1.37
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem (1986) 1.33
The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res (2000) 1.32
Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem J (1993) 1.32
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol (1987) 1.32
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study. FEBS Lett (1994) 1.32
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest (1991) 1.31
LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem (1999) 1.28
Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum (1986) 1.28
Subnormal levels of glucose in urine. A sign of urinary tract infection. JAMA (1967) 1.25
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem (2000) 1.24
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
[Cross-sectional field 14 pain medicine. Implementation of the German Pain Society (DGSS) core curriculum in the model study course MaReCuM]. Schmerz (2013) 1.21
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Insights into MMP-TIMP interactions. Ann N Y Acad Sci (1999) 1.18
Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem (1983) 1.18
Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand (2003) 1.17
Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. J Appl Physiol (1985) (1994) 1.17
The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur J Biochem (1996) 1.16
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur J Biochem (1995) 1.15
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J Cell Biol (1989) 1.14
Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett (1995) 1.14
Triabin, a highly potent exosite inhibitor of thrombin. J Biol Chem (1995) 1.14
Interleukin-8 synthesis and the onset of labor. Obstet Gynecol (1995) 1.12
Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors. Biophys J (1995) 1.12
[On protease inhibitors. I. Isolation and characterization of trypsin inhibitors from dog pancreas tissue and pancreas scretion]. Hoppe Seylers Z Physiol Chem (1966) 1.12
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem (2000) 1.11
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer (1986) 1.10
Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J (1994) 1.09
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J Mol Biol (2001) 1.08
Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur J Biochem (1998) 1.08
Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2. J Mol Biol (2006) 1.07
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. J Biol Chem (1985) 1.07
The primary structure of porcine glandular kallikreins. Adv Exp Med Biol (1979) 1.06
Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett (1993) 1.06
Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. Eur J Biochem (1990) 1.05
Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J Clin Chem Clin Biochem (1989) 1.05
Studies of ciliated epithelia of the human genital tract. 3: Mucociliary wave activity in organ cultures of human Fallopian tubes challenged with Neisseria gonorrhoeae and gonococcal endotoxin. Br J Vener Dis (1979) 1.05
New androgen response elements in the murine pem promoter mediate selective transactivation. Mol Endocrinol (2001) 1.04
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases. FEBS Lett (1996) 1.04
Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. Hoppe Seylers Z Physiol Chem (1977) 1.04
Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. FEBS Lett (1985) 1.04
Comparative study of the teratogenicity of phenobarbitone, diphenylhydantoin and carbamazepine in mice. Toxicology (1977) 1.04
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol (1988) 1.03
An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis. J Biol Chem (1994) 1.03
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer. Br J Cancer (1995) 1.03
Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J (1993) 1.03
Origin of cervical collagenase during parturition. Am J Obstet Gynecol (1992) 1.02
Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg (1992) 1.01
Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. Biochemistry (1995) 1.01
Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery (1985) 1.00
Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol (1995) 1.00
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med (1988) 1.00
The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J Mol Biol (1999) 0.99
The refined 2.2-A (0.22-nm) X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor. Eur J Biochem (1984) 0.99
Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event. Hum Genet (1992) 0.99
Mycoplasma in urine collected by suprapubic aspiration. Acta Med Scand (1972) 0.98
Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem (1995) 0.98
Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase. FEBS Lett (1990) 0.98
The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. FEBS Lett (1996) 0.97
Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur J Biochem (1986) 0.97
Characterization of an acid-stable proteinase inhibitor in human cervical mucus. Hoppe Seylers Z Physiol Chem (1974) 0.97
Transcripts for cysteine-rich secretory protein-1 (CRISP-1; DE/AEG) and the novel related CRISP-3 are expressed under androgen control in the mouse salivary gland. Endocrinology (1993) 0.97
Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology. Biol Chem Hoppe Seyler (1990) 0.97
[On the presence of a trypsin-plasmin inhibitor in hirudin]. Hoppe Seylers Z Physiol Chem (1969) 0.96
[ -Antitrypsin and c 1-inactivator: progressive inhibitors of human and porcine kallikrein]. Hoppe Seylers Z Physiol Chem (1972) 0.96
Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9. Braz J Med Biol Res (1994) 0.96
Genealogy of mammalian cysteine proteinase inhibitors. Common evolutionary origin of stefins, cystatins and kininogens. FEBS Lett (1985) 0.96
Safety and feasibility of nasopharyngeal evaporative cooling in the emergency department setting in survivors of cardiac arrest. Resuscitation (2010) 0.96
Lantent collagenase from human polymorphonuclear leucocytes and activation to collagenase by removal of a inhibitor. FEBS Lett (1980) 0.96
Complex-formation and inhibition of urokinase by blood plasma proteins. Biochem J (1983) 0.95